Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-13 Purchase | 2025-05-15 6:48 pm | Apimeds Pharmaceuticals US Inc. | APUS | Kim Christopher Chairman and CMO | 27,500 | $1.8312 | $50,359 | 27,500 (Direct) | View |
| 2025-05-12 Purchase | 2025-05-14 5:58 pm | Apimeds Pharmaceuticals US Inc. | APUS | Koo Jakap Director | 28,500 | $1.99 | $56,715 | 643,885 (Direct) | View |
| 2025-05-12 Purchase | 2025-05-14 5:52 pm | Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner | 500,000 | $4 | $2,000,000 | 6,416,365 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-12 Conversion(A) | 2025-06-11 4:36 pm | N/A N/A | Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner | 115,131 | $2.6 | 2,099,747 (Direct) | View |
| 2025-05-12 Conversion(A) | 2025-06-11 4:36 pm | N/A N/A | Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner | 299,340 | $0 | 2,099,747 (Direct) | View |
Ownership(A) | 2025-06-11 4:11 pm | N/A N/A | Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner | 0 | $0 | 6,391,777 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-20 5:18 pm | N/A 2035-05-16 | Apimeds Pharmaceuticals US Inc. | APUS | Kogan Elona Director | 5,780 | $0 | 5,780 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-20 5:11 pm | N/A 2035-05-16 | Apimeds Pharmaceuticals US Inc. | APUS | Yoon Hankil Director | 5,780 | $0 | 5,780 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-20 5:02 pm | N/A 2035-05-16 | Apimeds Pharmaceuticals US Inc. | APUS | O'DONNELL CAROL A Director | 5,780 | $0 | 5,780 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-20 5:00 pm | N/A N/A | Apimeds Pharmaceuticals US Inc. | APUS | Kim Christopher Chairman and CMO | 250,000 | $0 | 277,500 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-20 4:56 pm | N/A 2035-05-16 | Apimeds Pharmaceuticals US Inc. | APUS | Emerson Erik C. Chief Executive Officer | 1,097,279 | $0 | 1,097,279 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-20 4:46 pm | N/A 2035-05-16 | Apimeds Pharmaceuticals US Inc. | APUS | Weintraub Bennett Director | 5,780 | $0 | 5,780 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-20 4:38 pm | N/A 2035-05-16 | Apimeds Pharmaceuticals US Inc. | APUS | Koo Jakap Director | 5,780 | $0 | 5,780 (Direct) | View |
| 2025-05-12 Conversion | 2025-05-14 5:52 pm | N/A N/A | Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner | 297,133 | $2.6 | 6,416,365 (Indirect) | View |
| 2025-05-12 Conversion | 2025-05-14 5:52 pm | N/A N/A | Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner | 772,545 | $0 | 6,416,365 (Indirect) | View |
Ownership(A) | 2025-05-14 5:32 pm | N/A N/A | Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner | 0 | $0 | 6,391,777 (Direct) | View |
Ownership | 2025-05-08 5:31 pm | N/A N/A | Apimeds Pharmaceuticals US Inc. | APUS | Koo Jakap Director | 0 | $0 | 615,385 (Direct) | View |
Ownership | 2025-05-08 5:19 pm | N/A N/A | Apimeds Pharmaceuticals US Inc. | APUS | Inscobee Inc. 10% Owner | 0 | $0 | 5,619,234 (Direct) | View |
Ownership | 2025-05-08 5:06 pm | N/A 2030-05-12 | Apimeds Pharmaceuticals US Inc. | APUS | Kim Christopher Chairman and CMO | 0 | $0 | 213,692 (Direct) | View |